Our locations

With facilities throughout Europe, North America, and East Asia, we’re able to meet worldwide demand for innovative oral and transdermal drug delivery solutions.

Andernach

Our German headquarters is our original location, founded in 1984. This facility houses our largest production area.

R&D unit
Expertise in high potency APIs and hormones
Features a 23,000m² production area and a 14,000 pallet warehouse
Capable of producing over one billion units per year

West Caldwell

Our first North American site, acquired in 1994, expanded our production capabilities to North America.

Expertise in high potency APIs
Features a 10,200m² production area and a 9,300 pallet warehouse
Capable of producing over one billion units per year

St. Paul

Acquired in 2022, our St. Paul facility enhances our production capabilities and offers research and development capacities in North America.

R&D unit
Expertise in high potency APIs
Features a 2,500m² production area and a 1,500 pallet warehouse
Capable of producing over 300 million units per year

Netanya

Acquired in 2023, our first drug device facility offers production capabilities, as well as research and development capacities for wearable infusion pumps.